コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d glucose utilization in the muscle and poor exercise performance.
2 nessed to alter systemic fuel metabolism and exercise performance.
3 t, was the primary factor in such diminished exercise performance.
4 VRS and were associated with improvements in exercise performance.
5 late the flow abnormalities to the patients' exercise performance.
6 uction in lung volumes and an improvement in exercise performance.
7 esting were closely associated with improved exercise performance.
8 d airflow turbulence, contribute to limiting exercise performance.
9 ximal ventilation, thereby improving maximal exercise performance.
10 atment for emphysema, is reported to improve exercise performance.
11 keletal muscle and local as well as systemic exercise performance.
12 2+) handling in skeletal muscle and improves exercise performance.
13 ough PFO increases during exercise impairing exercise performance.
14 es for recovery and that augments subsequent exercise performance.
15 in regulating physical activity behavior and exercise performance.
16 so associated with a significant increase in exercise performance.
17 e, vigilance, symptoms, adverse effects, and exercise performance.
18 t of statins on skeletal muscle strength and exercise performance.
19 ermine if statins affect muscle strength and exercise performance.
20 s are critical regulators of skeletal muscle exercise performance.
21 mall and used crude measures of strength and exercise performance.
22 logy and improved muscle strength as well as exercise performance.
23 ised with artificial sweetener, would affect exercise performance.
24 y abrogated the positive effects of IL-37 on exercise performance.
25 (+)/K(+) transport in skeletal muscles or in exercise performance.
26 study and to identify factors that influence exercise performance.
27 and mode of operation do not influence early exercise performance.
28 on peripheral versus central determinants of exercise performance.
29 ovements in laboratory- and ambulatory-based exercise performance.
30 l disease patients with claudication-limited exercise performance.
31 d flow to limb locomotor muscles and reduces exercise performance.
32 ith an improved quality of life and improved exercise performance.
33 9 (2.08-3.47), and 14.61 (10.09-21.17); poor exercise performance-1.11 (0.94-1.31), 1.58 (1.33-1.88),
34 echin treatment and regular exercise on: (1) exercise performance, (2) muscle fatigue, (3) capillarit
35 rt Physical Performance Battery), submaximal exercise performance (6-Minute Walk Test), standing bala
36 tory Questionnaire total score, >/=25), poor exercise performance (6-minute-walk distance, <391 m), b
39 tation is due to deconditioning, we assessed exercise performance and cardiopulmonary function in sev
41 ontrolled clinical trial compared changes in exercise performance and daily ambulatory activity in pe
42 al artery disease have a marked reduction in exercise performance and daily ambulatory activity irres
48 d that beraprost would: 1) improve treadmill exercise performance and quality of life; and 2) decreas
50 of life because of a profound limitation in exercise performance and the potential to develop critic
51 mplications for improving physical activity, exercise performance, and brain-related function and out
52 D36 has a key role in muscle fuel selection, exercise performance, and training-induced muscle FAO ad
53 n (CRC group 59.4%; control group 62.5%) and exercise performance as assessed by peak oxygen consumpt
55 tigators assessed the quality of Chinese eye exercises performance at the end of the follow-up period
56 asingly popular for improving high-intensity exercise performance because it is the rate-limiting pre
59 ivates regions of the brain that can enhance exercise performance but direct evidence of such a mecha
60 ive ventilation reduces dyspnea and improves exercise performance, but current systems are unsuitable
62 to an inflammatory challenge, also improved exercise performance by 82% compared with vehicle-treate
63 ivation during exercise could interfere with exercise performance by impairing arteriolar dilation in
64 ntrolled trials show that treatment improves exercise performance by increasing lung volume rather th
75 at LVRS produces significant improvements in exercise performance, dyspnea, and quality of life in se
77 Glycogen depletion minimally affects maximal exercise performance, endurance or ventilation in CHF pa
78 y was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent at
81 it fatty acid oxidation, increased treadmill exercise performance; however, its long-term efficacy an
82 main physiological determinants of endurance exercise performance (i.e. maximal oxygen consumption ,
88 on versus rate control to focus on objective exercise performance in AF and HF shows significant bene
91 afil may be an important agent for improving exercise performance in children and young adults with s
92 o identify the perioperative determinants of exercise performance in children, adolescents and young
93 n: Reducing inspired gas density can improve exercise performance in COPD as much as increasing inspi
94 The mechanism responsible for diminished exercise performance in cystic fibrosis (CF) is not clea
95 adolescents are limited, and the patterns of exercise performance in different ages are unexplored.
97 lementation has been hypothesized to improve exercise performance in healthy humans through various m
98 travenous verapamil acutely enhances aerobic exercise performance in healthy older individuals in ass
100 does not decrease average muscle strength or exercise performance in healthy, previously untreated su
102 ly16 and Gln27 are associated with depressed exercise performance in HF and represent a genetically d
103 ence of systemic RV dysfunction and impaired exercise performance in long-term survivors of the Musta
107 eration of glycogen stores and metabolism on exercise performance in patients with heart failure.
108 ationship between pulmonary hypertension and exercise performance in patients with heart failure.
109 es forearm skeletal muscle bioenergetics and exercise performance in patients with idiopathic palmar
110 ion is widely used in improving symptoms and exercise performance in patients with ischemic heart dis
112 he hypothesis that NM-702 improves treadmill exercise performance in peripheral arterial disease pati
113 owed that a short-term high-fat diet blunted exercise performance in rats, accompanied by increased u
114 tianginal shown to reduce angina and improve exercise performance in selected patients with early-pos
116 hat ventilatory muscle recruitment (VMR) and exercise performance in stable hypercapnic patients woul
117 environments, and studies evaluating aerobic exercise performance in such environments across the men
118 strual cycle phase does not appear to affect exercise performance in the heat in well-trained women,
123 , and because cardiac function can influence exercise performance, it is the purpose of the present s
124 l muscles, and examined the consequences for exercise performance, membrane potentials, contractility
126 mbinant human IL-37 reverses the decrease in exercise performance observed during systemic inflammati
127 ch1 activation improves the regeneration and exercise performance of aged and dystrophic muscles.
128 The purpose of this study was to compare the exercise performance of LVAD patients with that of ambul
131 rt failure (cardiac dysfunction and impaired exercise performance) on optimal current therapy (97% en
132 erted a statistically significant benefit on exercise performance or frequency of ischemia during amb
133 e any clinically significant improvements in exercise performance or perceptions of dyspnea during ex
135 f AdVEGF121 was not associated with improved exercise performance or quality of life in this study.
136 , pulmonary function, maximal and submaximal exercise performance or quality-of-life questionnaires w
139 dy glycogen synthesis and impairs subsequent exercise performance, presumably because of lower hepati
140 cal summary score was associated with poorer exercise performance (R(2) adjusted = 0.20; p < 0.001; n
144 rinsing with a 6.4% maltodextrin solution on exercise performance, showing it to significantly reduce
145 jor determinants of central motor output and exercise performance switches from a predominantly perip
148 The results suggest that the improvement in exercise performance that is observed when carbohydrate
149 plasma glucose concentrations and decreased exercise performance the next day.Mixed meals containing
150 monotherapy was well tolerated and increased exercise performance throughout its dosing interval at a
151 (aO(2)) on locomotor muscle power output and exercise performance time is determined to a significant
152 -term temperature challenge affected aerobic exercise performance (U(crit)), but each T(E) group had
158 xpressed, diastolic function was normalized, exercise performance was improved, and pathological hype
161 of regular physical activity, their maximal exercise performance was reduced and was associated with
164 bsence of abdominal wall musculature impairs exercise performance we studied nine patients 6 to 31 yr
166 pometric characteristics, lung function, and exercise performance were similar for the 22 patients in
167 dies of Asian ginsengs found improvements in exercise performance when most of the following conditio
168 Higher O(2) pulse is associated with better exercise performance, whereas adolescence and male gende
169 ARbeta/delta mice are known to have enhanced exercise performance, whereas MCK-PPARalpha mice perform
170 eview, we describe changes in peak endurance exercise performance with advancing age as well as physi
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。